Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T12:46:03.907Z Has data issue: false hasContentIssue false
  • English
  • Français

5-HT2 receptors, hallucinations, and dementia

Published online by Cambridge University Press:  02 January 2018

Serdar M. Dursun
Serdar M. Dursun*
Affiliation:
Pharmaceutical Sciences Institute, Aston University, Aston Triangle, Birmingham B4 7ET
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 161 , Issue 5 , November 1992 , pp. 719
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

References

Cross, A. J., Crow, T. J., Ferrier, I. N., et al (1986) The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia. Neurobiology of Aging, 7, 3–7.Google Scholar
Glennon, R. A., Titeler, M. & McKenney, J. D. (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences, 35, 2505–2511.Google Scholar
Gross-Isseroff, R., Salama, D., Israeli, M. et al (1990) Autoradiographic analysts of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Research, 519, 223–227.Google Scholar
Leysen, J. E. & Pauwels, P. J. (1990) 5-HT2 receptors, roles and regulation. Annals of the New York Academy of Sciences, 600, 183–193.CrossRefGoogle ScholarPubMed
Pierce, A. P. & Peroutka, S. J. (1990) Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors. Neuropsychopharmacology, 3, 503–508.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.